Johnson & Johnson (JNJ) technical analysis

From the Sep 26, 2026 report · Read the full report

$271.95

+49.74% Sep 28, 2026

Indicators

Data as of Sep 28, 2026

Trend: Uptrend (price above the 50-day average, which is above the 200-day)

20-day average: $269.84
50-day average: $265.35
200-day average: $240.68
14-day RSI: 58.1; neutral
MACD (12/26/9): 1.41; below the signal (bearish momentum)
Signal line: 1.51; Histogram: -0.09

50-day average above the 200-day (golden cross)

Support and resistance

Relevant lows and highs of the last 6 months, computed from daily prices.

Resistance

$275.69
$281.07

Support

$269.43
$262.26

Performance

1M: +2.3%
3M: +5.2%
6M: +13.1%
1Y: +53.0%

From the Sep 26, 2026 report

JNJ's technical picture shows a strong bullish trend as of September 25, 2026. The stock price is trading significantly above both its long-term (200 SMA) and medium-term (50 SMA) moving averages, with price at $271.22 compared to 200 SMA at $238.26 (13.8% above) and 50 SMA at $264.28 (2.6% above). The short-term momentum (10 EMA) is at $269.64, with price just 0.6% above this level. However, the MACD histogram shows declining momentum (-0.26), indicating slowing upward momentum and potential near-term consolidation. The RSI remains neutral at 57.23, suggesting no immediate overbought conditions. The ATR (5-day) of $5.16 provides a clear stop-loss level at $266.06 (271.22 - 5.16), which serves as a key technical support level.

Frequently asked questions

What is the JNJ trend?

Uptrend (price above the 50-day average, which is above the 200-day)

Is JNJ overbought?

The 14-day RSI of JNJ is 58.1 (neutral) as of Sep 28, 2026.

Sources: Yahoo Finance (prices, financial statements and analysts' estimates) and the U.S. Treasury (10-year yield). Indicators and valuation are computed without AI.

AI-generated informational content. Not financial advice or a personalised investment recommendation. Investing involves risk, including loss of capital.

Every week, in your inbox

Rating changes, the highest-conviction stocks and the week's best research. Free.